Evidence mapPaperPMID 34684639Full record

Trial reportNutrients2021

Insulin/IGF-1 Signaling Is Downregulated in Barrett's Esophagus Patients Undergoing a Moderate Calorie and Protein Restriction Program: A Randomized 2-Year Trial.

Diletta Arcidiacono, Alice Zaramella, Federico Fabris, Ricardo Sánchez-Rodríguez, Daniele Nucci, Matteo Fassan, Mariateresa Nardi, Clara Benna, Chiara Cristofori, Tiziana Morbin and 3 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03813381 (The Impact of a Moderate CAlorie and Protein REstriction PROgram), which is not on this map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03813381 nacompletednot on this map

The Impact of a Moderate CAlorie and Protein REstriction PROgram (CARE-PRO) as an Efficient and Affordable Therapeutic Strategy in Patients With Barrett's Esophagus.

TypeinterventionalSponsorIstituto Oncologico Veneto IRCCSRan2015 to 2021Enrolled160ConditionsBarrett's Esophagus, Overweight and ObesityArmsCalorie and protein restriction diet
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Effects of Obesity and Calorie Restriction on Cancer Development.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Diletta ArcidiaconoGastroenterology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy.ORCID 0000-0002-4417-6513
Alice ZaramellaGastroenterology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy.
Federico FabrisDepartment of Biomedical Sciences, University of Padua, Viale Colombo 3, 35121 Padua, Italy.
Ricardo Sánchez-RodríguezDepartment of Biomedical Sciences, University of Padua, Viale Colombo 3, 35121 Padua, Italy.
Daniele NucciNutritional Support Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy.ORCID 0000-0003-4546-213X
Matteo FassanDepartment of Medicine (DIMED), Surgical Pathology Unit, University of Padua, Via Gabelli 61, 35121 Padua, Italy.ORCID 0000-0001-6515-5482
Mariateresa NardiNutritional Support Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy.
Clara BennaFirst Surgical Clinic, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35128 Padua, Italy.ORCID 0000-0002-9077-2471
Chiara CristoforiGastroenterology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy.ORCID 0000-0002-8156-2456
Tiziana MorbinGastroenterology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy.
Salvatore PucciarelliFirst Surgical Clinic, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35128 Padua, Italy.
Alberto FantinGastroenterology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy.
Stefano RealdonGastroenterology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy.
Istituto Oncologico Veneto · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity and associated insulin resistance (Ins-R) have been identified as important risk factors for esophageal adenocarcinoma development. Elevated calories and protein consumption are also associated with Ins-R and glucose intolerance. We investigated the effect of a 24-month moderate calorie and protein restriction program on overweight or obese patients affected by Barrett's esophagus (BE), as no similar dietary approach has been attempted to date in this disease context. Anthropometric parameters, levels of serum analytes related to obesity and Ins-R, and the esophageal insulin/IGF-1 signaling pathway were analyzed. This study is registered with ClinicalTrials.gov, number NCT03813381. Insulin, C-peptide, IGF-1, IGF-binding protein 3 (IGFBP3), adipokines, and esophageal expression of the main proteins involved in insulin/IGF-1 signal transduction were quantified using Luminex-XMAP

Indexed as

AdenocarcinomaAgedBarrett EsophagusBody Mass IndexCaloric RestrictionDiet, Protein-RestrictedDown-RegulationEsophageal NeoplasmsFemaleHumansInsulinInsulin-Like Growth Factor IInsulin ResistanceMaleMAP Kinase Signaling SystemMiddle AgedIGF1 protein, humanInsulinInsulin-Like Growth Factor IBarrett’s esophaguscalorie–protein restrictionesophageal adenocarcinoma preventioninsulin/IGF-1 signal transductionobesity

Identifiers

PMID34684639
PMCPMC8537306
OpenAlexW3205636255

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.